Juanjuan Shang
Papers
1
Total Citations
8
H-Index
1
About
Dr. Juanjuan Shang is a pioneering researcher at the intersection of nanomedicine and oncology, with a primary focus on developing advanced drug delivery systems for hepatocellular carcinoma (HCC)—the most common form of liver cancer and a leading cause of cancer-related deaths worldwide. Her most cited work introduces a groundbreaking strategy using dual-responsive magnetic DCR3 nanoparticles, which combine magnetic guidance with stimuli-responsive drug release to achieve unprecedented precision in targeting HCC tumors. This innovation addresses critical limitations of traditional molecularly targeted therapies, such as poor tumor penetration and systemic toxicity, by leveraging micro/nanorobotic principles to enhance drug accumulation and efficacy at the disease site. With 8 citations already for her 2024 publication, Dr. Shang’s research is rapidly gaining recognition for its potential to transform HCC treatment paradigms. Her contributions are particularly notable for integrating materials science, magnetic control, and tumor biology, offering a scalable platform for next-generation cancer nanotherapeutics. Dr. Shang’s work not only advances the field of targeted drug delivery but also provides a promising avenue for reducing side effects and improving patient outcomes in liver cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1